/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
KKR Real Estate Finance Trust Inc. Closes Two Senior Loans Totaling $602.5 Million
NEW YORK–(BUSINESS WIRE)–KKR Real Estate Finance Trust Inc. (the “Company” or “KREF”) (NYSE:KREF)
today announced the Company closed two floating-rate senior loans
totaling $602.5 million since the May 1st earnings release,
resulting in current second quarter 2019 originations of $785.1 million
across three senior loans. Year-to-date, KREF has originated five senior
loans totaling $999.1 million. As of today, the outstanding funded
portfolio is $4.3 billion.
Recent Investment Activity
In May 2019, KREF closed a $386.0 million floating-rate senior loan
secured by 857-units, across two luxury multifamily properties located
in Brooklyn, NY. The loan has a three-year initial term with two
one-year extension options, carries a coupon of LIBOR+2.7% and has an
appraised loan-to-value (“LTV”) of approximately 52%.
In addition, in May 2019, KREF closed a $216.5 million floating-rate
senior loan secured by a 1,070-unit, three property class-A multifamily
portfolio located in Atlanta, GA, Birmingham, AL and Fort Worth, TX. The
loan has a three-year initial term with two one-year extension options,
carries a coupon of LIBOR+3.5% and has an appraised LTV of approximately
74%.
The following table summarizes key features of the two recently closed
floating-rate senior loan transactions ($ in thousands):
|
|||||||||||||||||||||||||
Month | Maximum | Initial Face | Interest | ||||||||||||||||||||||
Description/Location | Property Type | Originated | Face Amount | Amount Funded | Rate(A) | Maturity Date(B) | LTV | ||||||||||||||||||
Senior Loan, Brooklyn, NY | Multifamily | May 2019 | $ | 386,000 | $ | 324,400 | L + 2.7% | June 2024 | 52 | % | |||||||||||||||
Senior Loan, Various | Multifamily | May 2019 | 216,500 | 171,850 | L + 3.5 | June 2024 | 74 | ||||||||||||||||||
Total/Weighted Average | $ | 602,500 | $ | 496,250 | L + 3.0% | 60 | % | ||||||||||||||||||
(A) Floating rate based on one-month USD LIBOR
(B) Maturity date
assumes all extension options are exercised.
About KREF
KKR Real Estate Finance Trust Inc. (NYSE:KREF) is a real estate finance
company that focuses primarily on originating and acquiring senior loans
secured by commercial real estate properties. KREF is externally managed
and advised by an affiliate of KKR & Co. Inc. For additional information
about KREF, please visit its website at www.kkrreit.com.
Forward-Looking Statements
This release contains certain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, which
reflect the Company’s current views with respect to, among other things,
its future operations and financial performance. The forward-looking
statements are based on the Company’s beliefs, assumptions and
expectations, taking into account all information currently available to
it. These beliefs, assumptions and expectations can change as a result
of many possible events or factors, not all of which are known to the
Company or are within its control, including those described under Part
I—Item 1A. “Risk Factors” of the Company’s Annual Report on Form 10-K
for the fiscal year ended December 31, 2018, filed with the Securities
and Exchange Commission (“SEC”), as such factors may be updated from
time to time in the Company’s periodic filings with the SEC.
Accordingly, actual outcomes or results may differ materially from those
indicated in this release. All forward looking statements in this
release speak only as of the date of this release. The Company
undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future developments or otherwise, except as required by law.
Definitions
“Loan-to-value ratio”: Generally based on the initial loan amount
divided by the as-is appraised value as of the date the loan was
originated.
Contacts
Media
Kristi Huller or Cara Major
(212) 750-8300
[email protected]
Investor
Relations
Michael Shapiro
(646) 901-5920
[email protected]
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
SCHWAZZE
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
DENVER, April 29, 2024 /PRNewswire/ — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), will host a conference call on Wednesday, May 15, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the first quarter ended March 31, 2024. The Company’s results will be reported in a press release prior to the call.
The Schwazze management team will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing [email protected].
Date: Wednesday, May 15, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 84167910
Webcast: SHWZ Q1 2024 Earnings Call
The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.
Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 167910
If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.
Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.
Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.
Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit http://www.schwazze.com/.
Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
[email protected]
View original content:https://www.prnewswire.co.uk/news-releases/schwazze-sets-first-quarter-2024-conference-call-for-may-15-2024-at-500-pm-et-302130423.html
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE18 hours ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET